UK NSC moves to 2-yearly open call cycle
UK NSC moves to 2-yearly open call cycle
UK NSC is moving to a 2-yearly cycle for inviting stakeholders to submit new screening topic proposals.
Simple screening comparisons between countries mask complex differences
Variation in how health services are delivered and funded, how screening is described and how screening policy is made help explain differences between countries and regions in what conditions they screen for.
UK NSC recommends introduction of screening for tyrosinaemia in newborns
The UK National Screening Committee is recommending the introduction of screening for tyrosinaemia as part of the newborn blood spot screening programme.
UK NSC receives record number of annual call screening proposals
The UK National Screening Committee (UK NSC) received a record number of 29 proposals during its 2022 annual call for topics. This is by far the most submissions it has received in a single year since the annual call process started in 2016.
UK NSC public engagement on genome sequencing wins prestigious award
A public dialogue on the implications of whole genome sequencing (WGS) for newborn screening, commissioned by the UK NSC, has won the 2022 Market Research Society (MRS) award for public policy/social research.
Work starts on reviewing the case for screening for SMA
Researchers start work on new project to review evidence for newborn screening for spinal muscular atrophy.
The role of patient and public voice members on the UK NSC
Find out more about the role of the UK NSC's patient and public voice members (PPVs) and the essential contribution they make to the work of the committee.
Why evidence maps are the UK NSC’s first step in reviewing screening evidence
Using evidence maps as the first stage in its evidence review process helps the UK NSC focus its more detailed work on topics where there is the most significant new evidence.
UK NSC screening manual describes best practice for national screening programmes
The new UK NSC screening manual sets out the evidence base, policy requirements, implementation processes, quality assurance requirements and core pathway components needed for national screening programmes.
Updated UK NSC evidence review guidance and processes
The UK NSC has published a new collection of documents on GOV.UK that describe its processes and principles for implementing the chief medical officers’ recommendations for the committee’s expanded remit.
UK NSC recommends introduction of targeted lung cancer screening
The UK NSC has recommended that the 4 UK nations should move towards implementing a targeted national lung cancer screening programme, integrated with smoking cessation services.